(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX,(r)-(+)-7 [4(S) -(苄基)恶唑- 2 -基]- 7 -双(3,5-二叔丁基苯基)膦- 2,2,3,3四氢- 1,1-螺二氢茚 , min. 97%
(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX
(r)-(+)-7 [4(S) -(苄基)恶唑- 2 -基]- 7 -双(3,5-二叔丁基苯基)膦- 2,2,3,3四氢- 1,1-螺二氢茚 , min. 97%
产品编号
15-5190
CAS
纯度
min. 97%
分子式
C55H66NOP
分子量
788.09
品牌
Strem
收藏
25mg
期货: 3~5 Weeks
   ¥ 1680
100mg
期货: 3~5 Weeks
   ¥ 5040

Technical Notes

1. Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of imines.

2.Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of a-ß unsaturated carboxylic acids.

3. Chiral ligands for iridium-catalyzed, asymmetric hydrogenation of a,-oxy-a,ß-

unsaturated carboxylic acids.

References:

1.J. Am. Chem. Soc., 2006, 128, 12886.

2J. Am. Chem. Soc., 2008, 130, 8584.

3.J. Am. Chem. Soc., 2010, 132, 1172.

产品分类